Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

348 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.
Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, O'Carroll C, Allen P, Seal ML, Fletcher PC, Crippa JA, Giampietro V, Mechelli A, Atakan Z, McGuire P. Bhattacharyya S, et al. Among authors: crippa ja. Arch Gen Psychiatry. 2009 Apr;66(4):442-51. doi: 10.1001/archgenpsychiatry.2009.17. Arch Gen Psychiatry. 2009. PMID: 19349314 Clinical Trial.
Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol.
Fusar-Poli P, Allen P, Bhattacharyya S, Crippa JA, Mechelli A, Borgwardt S, Martin-Santos R, Seal ML, O'Carrol C, Atakan Z, Zuardi AW, McGuire P. Fusar-Poli P, et al. Among authors: crippa ja. Int J Neuropsychopharmacol. 2010 May;13(4):421-32. doi: 10.1017/S1461145709990617. Epub 2009 Sep 24. Int J Neuropsychopharmacol. 2010. PMID: 19775500 Free article. Clinical Trial.
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown T, Nosarti C, O' Carroll CM, Seal M, Allen P, Mehta MA, Stone JM, Tunstall N, Giampietro V, Kapur S, Murray RM, Zuardi AW, Crippa JA, Atakan Z, McGuire PK. Bhattacharyya S, et al. Among authors: crippa ja. Neuropsychopharmacology. 2010 Feb;35(3):764-74. doi: 10.1038/npp.2009.184. Epub 2009 Nov 18. Neuropsychopharmacology. 2010. PMID: 19924114 Free PMC article. Clinical Trial.
Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study.
Winton-Brown TT, Allen P, Bhattacharyya S, Borgwardt SJ, Fusar-Poli P, Crippa JA, Seal ML, Martin-Santos R, Ffytche D, Zuardi AW, Atakan Z, McGuire PK. Winton-Brown TT, et al. Among authors: crippa ja. Neuropsychopharmacology. 2011 Jun;36(7):1340-8. doi: 10.1038/npp.2011.17. Epub 2011 Mar 16. Neuropsychopharmacology. 2011. PMID: 21412224 Free PMC article. Clinical Trial.
Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers.
Atakan Z, Bhattacharyya S, Allen P, Martín-Santos R, Crippa JA, Borgwardt SJ, Fusar-Poli P, Seal M, Sallis H, Stahl D, Zuardi AW, Rubia K, McGuire P. Atakan Z, et al. Among authors: crippa ja. Psychol Med. 2013 Jun;43(6):1255-67. doi: 10.1017/S0033291712001924. Epub 2012 Oct 1. Psychol Med. 2013. PMID: 23020923 Clinical Trial.
Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis.
Bhattacharyya S, Atakan Z, Martin-Santos R, Crippa JA, Kambeitz J, Malhi S, Giampietro V, Williams S, Brammer M, Rubia K, Collier DA, McGuire PK. Bhattacharyya S, et al. Among authors: crippa ja. Eur Neuropsychopharmacol. 2015 Jan;25(1):26-37. doi: 10.1016/j.euroneuro.2014.11.018. Epub 2014 Dec 4. Eur Neuropsychopharmacol. 2015. PMID: 25532865 Clinical Trial.
348 results